New Fully Automated Preparation of High Apparent Molar Activity ⁶⁸Ga-FAPI-46 on a Trasis AiO Platform

A large number of applications for fibroblast activation protein inhibitors (FAPI)-based PET agents have been evaluated in conditions ranging from cancer to non-malignant diseases such as myocardial infarction. In particular, ⁶⁸Ga-FAPI-46 was reported to have a high specificity and affini...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Chiara Da Pieve, Marta Costa Braga, David R. Turton, Frank A. Valla, Pinar Cakmak, Karl-Heinz Plate, Gabriela Kramer-Marek
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-01-01
Serie:	Molecules
Soggetti:	FAP gallium-68 FAPI-46 automated radiosynthesis Trasis AiO preclinical PET
Accesso online:	https://www.mdpi.com/1420-3049/27/3/675
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!